| Value | ₹160.0 Cr |
|---|---|
| Execution period | Commercial production expected by December 2027 |
NSE filing, NSE: BALRAMCHIN. Summary written from the filing by ALFA Finder's alert engine.
Balrampur Chini Mills Ltd: key numbers
- Share price
- ₹654.80
- Market cap
- ₹13,858 Cr
- Revenue (annual)
- ₹6,271 Cr
- Net profit (annual)
- ₹378.5 Cr
- P/E (TTM)
- 37.4×Sector 26.8×
- Promoter holding
- 42.79%-0.07% QoQ
- FII holding
- 8.96%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Balrampur Chini Mills Ltd
All →Balrampur Chini Mills Board Meeting Date
Balrampur Chini Mills will hold a board meeting on 4 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The board will also consider an interim dividend for FY 2026-27.
Balrampur Chini Mills Employee Stock Options
Balrampur Chini Mills Limited has granted 1,21,268 Employee Stock Appreciation Rights (ESARs) under its 2023 ESAR plan, with an exercise price of ₹721.25 per unit.
Balrampur Chini Mills Other Announcement
Balrampur Chini Mills Ltd has submitted its quarterly shareholding pattern report for the quarter ended September 30, 2026, in compliance with SEBI Regulation 31.
Balrampur Chini Mills Annual General Meeting
Balrampur Chini Mills Limited held its 50th Annual General Meeting on September 16, 2026. The meeting approved the financial statements and the final dividend.
Balrampur Chini Mills Other Announcement
Balrampur Chini Mills has sent a reminder intimation to physical shareholders, requesting them to update their KYC details and claim unpaid dividends or shares as mandated.
Balrampur Chini Mills Business Update
BCML received a ₹75 Crore BioE3 grant from BIRAC/DBT for a 100 TPA PLA R&D facility at Kumbhi, UP. It will advance India's biopolymer innovation and commercialisation.
- Value
- ₹75.00 Cr
- From
- BIRAC / Department of Biotechnology, Government of India
- PLA Co-Polymer R&D facility capacity
- 100 TPA
Other capacity expansion announcements
All →Cella Space Capacity Expansion
Cella Space signed a rent agreement for a new Mumbai branch office in Lower Parel. The branch aims to support business development and access to finance.
- new branch offices
- 1.0 branches
ATVO Enterprises Capacity Expansion: ₹0.56 Cr Investment
Atvo Enterprises Ltd proposes entering textile manufacturing via a new unit, with an estimated investment of Rs.0.56 Crore. The move diversifies the business into the textile sector.
- Value
- ₹0.56 Cr
Step Two Corporation Capacity Expansion: ₹10 Cr Investment
Step Two Corporation's board approved entry into retail financing of e-scooters, e-rickshaws and batteries, with an estimated investment of Rs.10 Crore. The move targets the growing e-vehicle and battery replacement market.
- Value
- ₹10.00 Cr
Step Two Corporation Capacity Expansion
Step Two Corporation will enter electric two-wheeler and battery lending, launching first in three locations. A new corporate logo was also adopted, a visual change only.
- initial launch locations
- 3.0 locations
Global Health Capacity Expansion: ₹997 Cr Investment
Medanta plans a 500-bed Ghaziabad hospital over 3-4 years. Project cost is Rs 997 Crore, funded by internal accruals and debt.
- Value
- ₹997.0 Cr
- Execution
- 3-4 years, phased
- hospital beds
- 500.0 beds
Gujarat Inject (Kerala) Capacity Expansion
Gujarat Inject Kerala Ltd leased two Ahmedabad industrial premises for factory and R&D use. The five-year deals include 5% escalation and a two-year lock-in.
- Execution
- 5 years (2-year lessee lock-in)